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Introduction
Common marmosets (Callithrix jacchus) have attracted increasing attention as a potentially useful non-human primate model in fields such as pharmacokinetics, toxicology, neuroscience, stem-cell research, immunology, and infectious disease because of their genetic closeness to humans, small body size (weighing 350-400 g on average), high reproductive efficiency (typically producing twins), early sexual maturity (reached within 18 months of age), and applicability of transgenic technologies (Orsi et al., 2011; Sasaki, 2015) . Cynomolgus monkeys (Macaca fascicularis) are the widely used non-human primate species for pharmacokinetics and drug safety testing in pharmaceutical companies.
Cytochrome P450s (P450s), the major drug-metabolizing enzymes comprising of multiple subfamilies, catalyze the oxidative biotransformation of potentially toxic compounds, including drugs and new chemical compounds (Wrighton and Stevens, 1992) . In humans, it has reported that approximately 75% of the drugs on the market are cleared by P450s and P450 3A enzymes significantly are involved in metabolism of more than 50% of the drugs (Williams et al., 2004) . In humans, the P450 3A subfamily consists of four members, namely P450 3A4, 3A5, 3A7, and 3A43 forms. Human P450 3A enzymes reportedly metabolize midazolam, alprazolam, nifedipine, and testosterone (Yamazaki et al., 2002; Ohtsuka et al., 2010) . P450 3A4 and 3A5 mRNAs are highly expressed in livers, followed by small intestines (among 10 human tissues) (Nishimura et al., 2003) , and their protein expression was also detected in livers (Yamazaki et al, 1995) and small intestines (Paine et al., 2006) . P450 3A4 protein expression was approximately 10-fold higher than that of P450 3A5 in human livers (Yamaori et al, 2004, DMD # 74898 5 orthologue, and 3A90 (http://drnelson.uthsc.edu/CytochromeP450.html). An our previous study showed that marmoset P450 3A4 orthologue and 3A90 enzymes effectively catalyzed midazolam 1´-hydroxylation, similar to human and cynomolgus monkey P450 3As (Uehara et al., 2016a) . Marmoset and cynomolgus monkey P450 3A4 orthologue also catalyzed omeprazole 5-hydroxylation and sulfoxidation reactions with high capacity (Uehara et al., 2016b) . Quantitative analysis of gene expression for common marmoset transcriptomes indicated that P450 3A4 orthologue and 3A5 orthologue /3A90 mRNAs were expressed in livers and small intestines, similar to human P450 3A mRNA (Shimizu et al., 2014) . P450 3A4 and 3A5 orthologue -like proteins were detected in marmoset livers (Schulz et al., 2001) . In spite of the potential importance as non-human primate model in drug metabolism and toxicological research, the molecular characteristics of marmoset P450 3A forms has not been analyzed in detail.
More than 20 marmoset P450 cDNAs have been identified so far; these P450s have high sequence similarities (>85%) to their orthologous human P450s (Uno et al., 2016) . Overall, substrate specificity and tissue expression of orthologous P450 enzymes are similar between marmosets and humans, except for some enzymes belonging to the P450 2 family. In this study, gene cluster organization, sequence similarity, tissue distribution, and enzymatic properties of marmoset P450 3A4 orthologue, 3A5 orthologue, and 3A90 were investigated. This work is of importance for understanding the metabolic characteristics of marmosets as animal models in drug development. DMD # 74898 7 other regents used were the highest quality commercially available.
Bioinformatics
The structure of marmoset P450 3A gene cluster was analyzed by BLAT (UCSC Genome Bioinformatics, University of California, Santa Cruz, CA) and by GGGenome (DNA Data Bank of Japan, National Institute of Genetics, Mishima, Japan). The amino acid sequence similarity of marmoset P450 3A forms compared with other species P450 3A members was determined by BLAST (National Center for Biotechnology Information, Bethesda, MD). The amino acid sequence alignment was performed using Genetyx system (Software Development, Tokyo, Japan). The phylogenetic tree was constructed with the aligned sequences by the neighbor-joining method using DNASIS Pro (Hitachi Software, Tokyo, Japan). P450 amino acid sequences used were from GenBank: human P450 3A4 (NP_059488), 3A5 (NP_000768), 3A7 (NP_000756), 3A43 (NP_073731), and 2D6 (NP_000097); chimpanzee P450 3A4 (NP_001116247), 3A5 (NP_001087246), and 3A7 (NP_001087243); orangutan P450 3A43 (ABU85093) and 3A67 (ABU85096); cynomolgus monkey P450 3A4 (NP_001271463), 3A5 (NP_001306440), 3A7 (NP_001306436), and 3A43 (NP_001306434); rhesus monkey P450 3A4 (NP_001035504), P450 3A5 (NP_001035309), and P450 3A7 (NP_001182687); marmoset P450 3A4 orthologue (NP_001191369), 3A5 orthologue (NP_001191371), and 3A90 (NP_001191372); dog P450 3A12 (NP_001003340) and 3A26 (NP_001003338); pig P450 3A22 (NP_001182438), 3A29 (NP_999588), 3A39 (NP_999587), and 3A46 (NP_001128296); rabbit P450 3A6 (NP_001164739); guinea pig P450 3A14 (NP_001166587), 3A15 (NP_001166588), and 3A17 (NP_001166540); rat P450 3A2 (NP_695224), 3A9 (NP_671739), 3A18 (NP_665725), 3A23 (NP_037237), and 3A62 (NP_001019403); mouse P450 3A11 (NP_031844), 3A13 (NP_031845), 3A16 (NP_031846), 3A25 (NP_062766), 3A41 DMD # 74898 8 (NP_001098629), 3A44 (NP_796354), 3A57 (NP_001093650), and 3A59 (NP_001098630).
Quantitative reverse transcription PCR
The P450 3A mRNA distribution in marmoset tissues was analyzed by real-time reverse transcription (RT)-polymerase chain reaction (PCR) as described previously (Uehara et al., 2016d) . Briefly, total RNAs were extracted from brains, lungs, livers, kidneys, and small intestines, each pooled from 12 adult marmosets (6 males and 6 females, >2 years old), using an RNeasy Mini Kit (Qiagen, Valencia, CA) and were used to synthesize cDNA using SuperScript III RT reverse transcriptase (Invitrogen, Carlsbad, CA, U.S.A.) with random hexamers in a 20-µl reaction. Quantitative RT-PCR was performed with SYBR Green-based detection system using gene-specific primers; 5-GCTTTTGGAAGTTTGACATGGA-3 and 5-CAGGCTGTCGACCATCATAAATC-3 for marmoset P450 3A4 orthologue, 5-GTGAAGAAGTTCCTAAAATTTGATTTCC-3 and 5-GGGGTAAGGAACGGGAAGAA-3 for marmoset P450 3A5 orthologue, and 5-CCTAAAATTTGATGTATTAGCTCCACTG-3 and 5-GGATAAGGAACGGAAAGAGTACTACTGA-3 for marmoset P450 3A90. The reaction mixture contained 400 nM of each primer, 12.5 µl of Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA), 2 µl of template DNA in in a total volume of 25 µl. The PCR conditions were as follows: an initial denaturation for 10 minutes at 95°C, followed by 40 cycles of 95 °C for 15 seconds and 60°C for 1 minute. Real-time PCR was performed with an ABI PRISM 7300 sequence detection system (Applied Biosystems). This study performed absolute quantification, displaying high PCR efficiency (>93%) comparable for three P450 genes with high correlation coefficient (r > 0.99). Standard curves were created by absolute amounts (10 2 -10 6 copies) with 10-fold dilution series of purified PCR products of marmoset P450 3A cDNAs. The expression level of each P450 3A mRNA was normalized to DMD # 74898 the level of 18S rRNA measured using Eukaryotic 18S rRNA Endogenous Control (Applied Biosystems).
Heterologous protein expression in Escherichia coli
Marmoset P450 3A4 orthologue, 3A5 orthologue, and 3A90 cDNAs were cloned from liver by RT-PCR as described previously (Uehara et al., 2015c) . In order to enhance the efficiency of expression for recombinant marmoset P450 3A proteins, the N-terminus modification was performed for the expression plasmids constructed with the P450 3A cDNAs by PCR using the forward and reverse primers; cjCYP3A4 (5exp1) 5-CATATGGCTCTGTTATTAGCAGTTTTCCTGGTGCTTCTGTATCTA-3 and cjCYP3A4
(3exp1) 5-TCTAGATTAGGCTCCACTTACAGTCC-3 for marmoset P450 3A4 orthologue,
and cjCYP3A5 (3exp1) 5-TCTAGATTATTCTCCACTTAGGGTTC-3 for marmoset P450 3A5 orthologue, and cjCYP3A4 (5exp1) 5-CATATGGCTCTGTTATTAGCAGTTTTCCTGGTGCTTCTGTATCTA-3 and cjCYP3A5
(3exp1) 5-TCTAGATTATTCTCCACTTAGGGTTC-3 for marmoset P450 3A90. PCR amplification was carried out for 30 cycles (denaturation at 98°C for 15 seconds, annealing at 60°C for 30 seconds, and extension at 68°C for 2 minutes) using KOD-Plus-Neo DNA polymerase (Toyobo, Osaka, Japan) with an ABI GeneAmp PCR System 2720 thermocycler (Applied Biosystems). PCR products were cloned into pGEM-T easy vectors (Promega, Madison, WI), and subsequently subcloned into pCW vectors using the restriction sites of the NdeI and XbaI sites (underlined). Recombinant P450 3A proteins were prepared in Escherichia coli DH5α expression system, and the concentration of P450 and NADPH-P450 reductase in each membrane preparation was measured as described previously (Yamazaki et al., 2002) .
Recombinant proteins were produced on the yield of approximately 2 μmol/L culture medium.
Recombinant marmoset P450 2D6 and 2D8, recombinant cynomolgus monkey 3A4 and 3A5, and recombinant human P450 3A4, 3A5, and 2D6 were prepared as described previously (Yamazaki et al., 2002; Uno et al., 2010; Uehara et al., 2015a) .
Western blotting
Recombinant P450 proteins (1.0 pmol) or liver microsomes (10 μg) were subjected to 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis, and then electrophoretically transferred to polyvinylidene difluoride membrane (Merck Millipore, Billerica, MA). After blocking with 0.5% non-fat milk in TBS (50 mM Tris, 138 mM NaCl, 2.7 mM KCl) containing 0.05% Tween 20 (v/v) (TBST) at room temperature for 30 minutes, the membrane was probed with anti-human P450 3A4 antibodies (1:2,000), anti-human P450 3A5 antibodies (1:5,000), anti-human P450 2D6 antibodies (1:10,000), or anti-human PDI antibodies (1:200) at room temperature for 1 hour, and then with goat-anti-rabbit IgG antibodies (1:5,000) at room temperature for 20 minutes. The antigen-antibody complex was visualized by an ECL Prime Western Blotting Detection System (GE Healthcare, Buckinghamshire, UK).
Enzyme assay
Midazolam 1´-and 4-hydroxylation, nifedipine oxidation, testosterone 6β-hydroxylation, and bufuralol 1´-hydroxylation activities by recombinant P450 proteins and tissue microsomes were measured as described previously (Yamazaki et al., 2002; Uehara et al., 2015b (Emoto et al., 2001; Shimizu, et al., 2007; Okada, et al., 2009) 
Results
Determination of P450 3A gene cluster structure and amino acid sequences identity in marmosets
The structure of marmoset P450 3A gene cluster was determined using marmoset genomic sequence by BLAT. Marmoset P450 3A cluster was localized in marmoset chromosome 2 (chr2: 12136811-12255660) (Fig. 1 ). Three marmoset P450 3A genes (P450 3A4 orthologue, 3A5 orthologue, and 3A90) form a cluster of total length 118850 bp (containing two gaps)
between ZSCAN25 and TRIM4 genes on the short arm of chromosome 2. No marmoset P450
3A genes had one-to-one orthologous relationship to human or cynomolgus monkey P450 3A
genes. A marmoset P450 3A43 ortholog was not found in the genome as analyzed by BLAT, or
GGGenome. The amino acid sequences of marmoset P450 3A4 orthologue, 3A5 orthologue, and 3A90 had six substrate recognition sites and a heme-binding site, similar to human and cynomolgus monkey P450 3A forms (Fig. 2) . Amino acid sequences of marmoset P450 3A4 orthologue, 3A5 orthologue, and 3A90 showed high degrees of identity (>88%) to those of human and cynomolgus monkey P450 3A forms (Table 1) . Phylogenetic analysis using amino acid sequences of the P450 3A forms from 12 species showed that marmoset P450 3A forms
were evolutionarily closer to the P450 3A forms of primates, including humans, chimpanzees, orangutans, rhesus monkeys, and cynomolgus monkeys, than those of dogs, pigs, guinea pigs, rats, and mice (Fig. 3 ).
Tissue distribution of three P450 3A mRNAs and proteins in marmosets
Expression levels of marmoset P450 3A mRNAs in brains, lungs, livers, kidneys, and small intestines were analyzed by real-time RT-PCR. All three marmoset P450 3A mRNAs were abundantly expressed in livers and small intestines among the five tissues examined (Fig. 4) . DMD # 74898 13 The expression level of P450 3A4 orthologue mRNA was >5-fold (livers) and >3-fold (small intestines) higher than those of P450 3A5 orthologue and 3A90 mRNAs, respectively, indicating that P450 3A4 orthologue was the major P450 3A form in livers and small intestines, the organs responsible for drug metabolism. P450 3A5 orthologue mRNA was >7-fold higher in small intestines than livers, different from P450 3A4 orthologue and 3A90 mRNAs expressed in these tissues at comparable levels. Tissue distribution of P450 3A proteins in marmosets was investigated by Western blotting using anti-human P450 3A4 and 3A5
antibodies capable of detecting selectively recombinant marmoset P450 3A proteins (Fig. 5A ).
P450 3A4 orthologue and 3A5 orthologue /3A90 proteins were detected in marmoset livers and small intestines (Fig. 5B) ; abundant P450 3A4 orthologue protein was detected in marmoset livers. P450 3A4 orthologue and 3A5 orthologue /3A90 proteins were constitutively expressed in livers from five individual marmosets (Fig. 5C ).
Enzymatic activities of marmoset P450 3A proteins
To assess the enzymatic function of marmoset P450 3A enzymes, the drug oxidation activities by recombinant P450 3A proteins and tissue microsomes were measured using typical human P450 3A probe substrates (midazolam, alprazolam, nifedipine, and testosterone). Liver and small intestine microsomes from marmosets catalyzed midazolam 1´-and 4-hydroxylation, alprazolam 4-hydroxylation, nifedipine oxidation, and testosterone 6β-hydroxylation in the similar manner to those of humans and cynomolgus monkeys (Table 2) ; liver microsomes from marmoset and cynomolgus monkeys catalyzed these reactions more strongly compared with those from humans. All marmoset P450 3A4 orthologue, 3A5 orthologue, and 3A90 enzymes also metabolized above typical human P450 3A probe substrates. Catalytic activities of P450 3A4 orthologue enzyme were the highest among the marmoset P450 3A enzymes analyzed.
This article has not been copyedited and formatted. The final version may differ from this version. Bufuralol 1´-hydroxylation activities, a typical human P450 2D probe activity, were higher for marmoset P450 3A4 orthologue, 3A5 orthologue, and 3A90 than human P450 3A4 and 3A5, similar to cynomolgus monkey P450 3A4 and 3A5 reported previously (Emoto et al., 2011) .
Kinetic analyses indicated that marmoset liver microsomes more effectively catalyzed midazolam 1´-hydroxylation (Vmax/Km, 0.74 mL/min/mg protein) with substrate inhibition kinetic, compared with those of human and cynomolgus monkey (Vmax/Km, 0.38 and 0.33 mL/min/mg protein, respectively) ( Table 3 and Fig. 6 ). Marmoset P450 3A4 orthologue enzyme was the most effective catalytic enzyme (Vmax/Km, 14 mL/min/nmol) for midazolam 1´-hydroxylation with substrate inhibition kinetic among the marmoset, cynomolgus monkey, and human P450 3A enzymes, and showed low Km value (2.5 μM), comparable to liver microsomes (8.1 μM) and small intestine microsomes (6.6 μM) from marmosets. Similarly, kinetic analyses indicated that marmoset liver microsomes effectively catalyzed nifedipine oxidation (Vmax/Km, 0.24 mL/min/mg protein) comparable to those from human and cynomolgus monkey (Vmax/Km, 0.25 and 0.35 mL/min/mg protein, respectively) ( Table 4 and lower than cDNA-expressed marmoset P450 2D6 (a major hepatic P450 2D enzyme) ( Table   2 ). When considered together with high levels of P450 3A proteins in livers, P450 3A enzymes might play another important role for bufuralol 1´-hydroxylation by marmoset livers.
This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
In marmosets, three P450 3A genes were identified (Qiu et al., 2008) ; however, the molecular characteristics have not been clarified. In this study, we investigated the sequence identity, the tissue distribution, and the enzymatic function of marmoset P450 3A forms. Marmoset P450 3A forms were highly identical (>88%) to the human and cynomolgus monkey P450 3A orthologues (Table 1) . A phylogenetic tree created using amino acid sequences showed that marmoset P450 3A forms were clustered with P450 3A forms from other primates, different from P450 3A forms found in preclinical animal species including dogs, pigs, and rodents ( Fig.   3 ). The high similarity of P450 3A amino acid sequences between marmosets, cynomolgus monkeys, and humans suggested a possibility that the enzymatic function of P450 3A was conserved among these primate species.
Among the marmoset P450 3A enzymes, P450 3A4 orthologue most abundantly expressed in livers and small intestines effectively catalyzed the oxidation of midazolam and nifedipine (Table 3 and as key residues for substrate binding and regioselectivity (He et al., 1997; Fowler et al., 2000; Fowler et al., 2002; Khan et al., 2002) . These amino acid residues on human P450 3A4 were completely shared with marmoset and cynomolgus monkey P450 3A4 orthologue, suggesting that the enzymatic function of P450 3A4 orthologue enzyme was highly conserved between marmosets, cynomolgus monkeys, and humans. Therefore, marmosets might be a suitable model for evaluating the P450 3A-dependent drug metabolism in preclinical studies.
Oxidation of bufuralol, a typical human P450 2D probe, were fast in marmoset livers than human livers (Table 2 ). Bufuralol 1´-hydroxylation activities were also higher for marmoset P450 3A enzymes than human P450 3A enzymes, although those activities by marmoset P450
2D6 enzyme (major P450 2D enzyme responsible for bufuralol 1´-hydroxylation in marmoset liver in term of expression level and enzyme kinetics) were comparable to human P450 2D6 (Uehara et al., 2015a) . In correlation analyses with 23 individual marmoset liver microsomes ( Fig. 7) suggested contributions of P450 3A enzymes to 1´-hydroxylation of midazolam (human P450 3A probe) and bufuralol (human P450 2D6 probe). Similarly, cynomolgus monkey P450 3A4 and/or 3A5 enzymes showed higher velocity than human P450 3A enzymes
for bufuralol 1´-hydroxylation and dextromethorphan O-dealkylation (Emoto et al., 2011; Selvakumar et al., 2014) . Hence, P450 3A enzymes might account for the higher velocity of bufuralol 1´-hydroxylation in marmoset and cynomolgus monkey livers.
In addition to drugs, P450 enzymes have various important physiological functions including the metabolism of steroids, bile acids, vitamins, and prostaglandins (Nebert and Dalton, 2006) .
In humans, P450 3A4 play major roles in testosterone 16β-, 6β-, and 2β-hydroxylation and progesterone 16α-, 6β-, and 2β-hydroxylation (Yamazaki and Shimada, 1997; Niwa et al., 2015) . Progesterone metabolism in humans is most similar to those in cynomolgus monkeys and least similar to those in rats (Swinney, 1990) . In this study, P450 3A4 orthologue, 3A5
orthologue, and 3A90 enzymes catalyzed testosterone 6β-hydroxylation, like human P450 3A enzymes ( humans, further study is needed to investigate the role of P450 enzymes for the metabolism of various endogenous compounds.
In humans, P450 3A4 and 3A5 mRNAs are abundant in livers and small intestines among the ten human tissues (Nishimura et al., 2003) , and these proteins are expressed in human livers and small intestines (Gibbs et al., 1999; Paine et al., 2006) . Marmoset P450 3A4
orthologue, 3A5 orthologue, and 3A90 mRNAs and proteins were also expressed in livers and small intestines among the five tissues (Figs. 4 and 5) , suggesting a possibility that the basal transcriptional regulation of P450 3A genes was shared between marmosets and humans. Marmoset P450 3A cluster contained two genes orthologous to human P450 3A5 genes, P450 3A5 orthologue and 3A90 (Fig. 1) . By phylogenomics analysis of primate P450 3A locus structure, marmoset P450 3A4 orthologue shared a common ancestry with catarrhine P450 3A4, while marmoset P450 3A5 orthologue and 3A90 shared a common ancestry with catarrhine and 3A90 with that of P450 3A4 orthologue in marmosets by exhaustive analysis of substrate specificity using xenobiotics and endogenous compounds.
In conclusion, amino acid sequences of three marmoset P450 3A forms showed high sequence identities (>87%) with P450 3A forms of cynomolgus monkeys, great apes, and humans, and phylogenetically had the close relationship with the human counterparts. P450
3A4 orthologue mRNA was abundant in marmoset livers and small intestines among three P450 3A mRNAs; P450 3A4 orthologue and 3A5 orthologue/3A90 proteins were also detected in these organs contributing to the drug metabolism. Recombinant P450 3A4 orthologue, 3A5
orthologue, and 3A90 enzymes prepared in Escherichia coli membranes catalyzed typical human P450 3A probe substrates, suggesting that P450 3A function was highly conserved between marmosets and humans. The significant correlation relationship between P450 3A4 orthologue contents and midazolam 1´-hydroxylation activities in marmoset livers showed that P450 3A4 orthologue enzyme greatly contributed to midazolam 1´-hydroxylation in marmoset liver microsomes. These results indicated that marmoset P450 3A forms have functional similarities with those of humans in terms of tissue expression and enzymatic properties. The structure of P450 3A gene cluster in marmoset, cynomolgus monkey, and human genome was analyzed by BLAT. Three marmoset P450 3A genes were located adjacent to ZSCAN25 and TRIM4 in the genome region corresponding to human and cynomolgus P450 3A
genes. This schematic diagram is not proportionate to actual size and distance on the chromosome. 3A67  87  80  80  3A43  76  74  74  Cynomolgus monkey  3A4  90  82  81  3A5  83  89  88  3A7  87  79  79  3A43  76  73  74  Dog  3A12  78  77  77  3A26  76  75  75  Pig  3A22  75  73  73  3A29  75  75  73  3A39  74  75  73  3A46  75  74  72  Rabbit  3A6  75  75  74  Rat  3A2  71  70  70  3A9  77  76  75  3A18  69  69  68  3A23  71  72  71  3A62  71  72  71  Mouse  3A11  73  73  72  3A13  75  75  74  3A16  69  69  69  3A25  71  70  69  3A41  70  71  70  3A44  69  69  69  3A57  69  67  67  3A59  70  69  68  Marmoset  3A4 Human 3A4 52 ± 2 1.6 ± 0.1 123 ± 2 2.4
Human 3A5 78 ± 6 2.3 ± 0.2 121 ± 7 1.6 a n represents the Hill coefficient. Kinetic parameters were determined by non-linear regression analysis (mean ± standard error, n = 12 points of substrate
for Hill equation (Emoto et al., 2001; Okada et al., 2009 ..***.*.** *..*.*..** ***.****** .*.***.*** ***. ***.. .*.****.** *****..* . *..*.**** .****..*** * *..* *. This article has not been copyedited and formatted. The final version may differ from this version. 
